| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | myosin V binding | 1.18e-05 | 20 | 145 | 4 | GO:0031489 | |
| GeneOntologyMolecularFunction | peptide-glutamate-alpha-N-acetyltransferase activity | 5.24e-05 | 2 | 145 | 2 | GO:1990190 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 7.21e-05 | 31 | 145 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | peptide-serine-alpha-N-acetyltransferase activity | 1.56e-04 | 3 | 145 | 2 | GO:1990189 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 2.60e-04 | 78 | 145 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.83e-04 | 18 | 145 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | glutathione binding | 2.83e-04 | 18 | 145 | 3 | GO:0043295 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | DENND4A PSD3 SRGAP2 RGS10 TBC1D9 ASAP2 FAM13A ARHGEF9 DOCK7 VAV3 PLCE1 SOS2 | 3.36e-04 | 507 | 145 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | DENND4A PSD3 SRGAP2 RGS10 TBC1D9 ASAP2 FAM13A ARHGEF9 DOCK7 VAV3 PLCE1 SOS2 | 3.36e-04 | 507 | 145 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | oligopeptide binding | 3.91e-04 | 20 | 145 | 3 | GO:1900750 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 5.16e-04 | 5 | 145 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 5.16e-04 | 5 | 145 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 8.30e-04 | 151 | 145 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 8.92e-04 | 102 | 145 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 9.74e-04 | 104 | 145 | 5 | GO:0016407 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 1.07e-03 | 7 | 145 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.08e-03 | 28 | 145 | 3 | GO:0141052 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 1.19e-03 | 29 | 145 | 3 | GO:0004364 | |
| GeneOntologyMolecularFunction | peptide alpha-N-acetyltransferase activity | 1.42e-03 | 8 | 145 | 2 | GO:0004596 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.45e-03 | 31 | 145 | 3 | GO:0032452 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.52e-03 | 231 | 145 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.59e-03 | 32 | 145 | 3 | GO:0140457 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.74e-03 | 33 | 145 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | modified amino acid binding | 1.98e-03 | 122 | 145 | 5 | GO:0072341 | |
| GeneOntologyBiologicalProcess | nitrobenzene metabolic process | 1.35e-06 | 4 | 145 | 3 | GO:0018916 | |
| GeneOntologyBiologicalProcess | melanosome transport | 1.55e-05 | 22 | 145 | 4 | GO:0032402 | |
| GeneOntologyBiologicalProcess | establishment of melanosome localization | 1.87e-05 | 23 | 145 | 4 | GO:0032401 | |
| GeneOntologyBiologicalProcess | pigment granule transport | 1.87e-05 | 23 | 145 | 4 | GO:0051904 | |
| GeneOntologyBiologicalProcess | establishment of pigment granule localization | 2.23e-05 | 24 | 145 | 4 | GO:0051905 | |
| GeneOntologyBiologicalProcess | melanosome localization | 2.64e-05 | 25 | 145 | 4 | GO:0032400 | |
| GeneOntologyBiologicalProcess | pigment granule localization | 3.11e-05 | 26 | 145 | 4 | GO:0051875 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid biosynthetic process | 4.85e-05 | 29 | 145 | 4 | GO:0042759 | |
| GeneOntologyBiologicalProcess | apoptotic nuclear changes | 1.29e-04 | 37 | 145 | 4 | GO:0030262 | |
| GeneOntologyBiologicalProcess | cellular component disassembly involved in execution phase of apoptosis | 1.59e-04 | 39 | 145 | 4 | GO:0006921 | |
| MousePheno | increased susceptibility to injury | DSP NEB RYR2 CFHR4 SLC8A3 AIFM1 MYDGF ITPRIP STIP1 CLSPN PLCE1 | 1.45e-06 | 208 | 118 | 11 | MP:0005165 |
| Domain | GST_mu | 4.44e-06 | 5 | 144 | 3 | IPR003081 | |
| Domain | SH3_1 | 2.84e-04 | 164 | 144 | 7 | PF00018 | |
| Domain | MAGUK_N_PEST | 3.51e-04 | 4 | 144 | 2 | PF10608 | |
| Domain | PDZ_assoc | 3.51e-04 | 4 | 144 | 2 | PF10600 | |
| Domain | DLG1_PEST_dom | 3.51e-04 | 4 | 144 | 2 | IPR019590 | |
| Domain | PDZ_assoc | 3.51e-04 | 4 | 144 | 2 | IPR019583 | |
| Domain | Gal_mutarotase_N | 3.51e-04 | 4 | 144 | 2 | IPR031727 | |
| Domain | MAGUK_N_PEST | 3.51e-04 | 4 | 144 | 2 | SM01277 | |
| Domain | DLG1 | 3.51e-04 | 4 | 144 | 2 | IPR016313 | |
| Domain | NtCtMGAM_N | 3.51e-04 | 4 | 144 | 2 | PF16863 | |
| Domain | GST_N | 6.21e-04 | 22 | 144 | 3 | PF02798 | |
| Domain | GST_NTER | 6.21e-04 | 22 | 144 | 3 | PS50404 | |
| Domain | Acetyltransf_1 | 7.10e-04 | 23 | 144 | 3 | PF00583 | |
| Domain | JmjC | 8.07e-04 | 24 | 144 | 3 | PF02373 | |
| Domain | RIH_assoc-dom | 8.68e-04 | 6 | 144 | 2 | IPR013662 | |
| Domain | Glyco_hydro_31_AS | 8.68e-04 | 6 | 144 | 2 | IPR030458 | |
| Domain | DUSP | 8.68e-04 | 6 | 144 | 2 | PF06337 | |
| Domain | Ins145_P3_rec | 8.68e-04 | 6 | 144 | 2 | PF08709 | |
| Domain | RIH_assoc | 8.68e-04 | 6 | 144 | 2 | PF08454 | |
| Domain | DUSP | 8.68e-04 | 6 | 144 | 2 | SM00695 | |
| Domain | RIH_dom | 8.68e-04 | 6 | 144 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 8.68e-04 | 6 | 144 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 8.68e-04 | 6 | 144 | 2 | IPR015925 | |
| Domain | - | 8.68e-04 | 6 | 144 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 8.68e-04 | 6 | 144 | 2 | PF01365 | |
| Domain | GNAT_dom | 9.12e-04 | 25 | 144 | 3 | IPR000182 | |
| Domain | GNAT | 9.12e-04 | 25 | 144 | 3 | PS51186 | |
| Domain | Bromodomain_CS | 1.02e-03 | 26 | 144 | 3 | IPR018359 | |
| Domain | GST_C | 1.02e-03 | 26 | 144 | 3 | IPR004046 | |
| Domain | GST_C | 1.02e-03 | 26 | 144 | 3 | PF00043 | |
| Domain | Glutathione_S-Trfase_N | 1.15e-03 | 27 | 144 | 3 | IPR004045 | |
| Domain | Glyco_hydro_31 | 1.21e-03 | 7 | 144 | 2 | IPR000322 | |
| Domain | DUSP | 1.21e-03 | 7 | 144 | 2 | PS51283 | |
| Domain | Glyco_hydro_31 | 1.21e-03 | 7 | 144 | 2 | PF01055 | |
| Domain | - | 1.21e-03 | 7 | 144 | 2 | 3.30.2230.10 | |
| Domain | GAF | 1.21e-03 | 7 | 144 | 2 | PF01590 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 1.21e-03 | 7 | 144 | 2 | PS00129 | |
| Domain | Pept_C19_DUSP | 1.21e-03 | 7 | 144 | 2 | IPR006615 | |
| Domain | SH3 | 1.45e-03 | 216 | 144 | 7 | SM00326 | |
| Domain | SH3 | 1.45e-03 | 216 | 144 | 7 | PS50002 | |
| Domain | GAF | 1.60e-03 | 8 | 144 | 2 | IPR003018 | |
| Domain | Trefoil | 1.60e-03 | 8 | 144 | 2 | PF00088 | |
| Domain | GAF | 1.60e-03 | 8 | 144 | 2 | SM00065 | |
| Domain | SH3_domain | 1.61e-03 | 220 | 144 | 7 | IPR001452 | |
| Domain | JMJC | 1.89e-03 | 32 | 144 | 3 | PS51184 | |
| Domain | JmjC_dom | 1.89e-03 | 32 | 144 | 3 | IPR003347 | |
| Domain | - | 2.05e-03 | 9 | 144 | 2 | 3.30.450.40 | |
| Domain | P_TREFOIL_2 | 2.05e-03 | 9 | 144 | 2 | PS51448 | |
| Domain | NaCa_Exmemb | 2.05e-03 | 9 | 144 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 2.05e-03 | 9 | 144 | 2 | PF01699 | |
| Domain | GAF_dom-like | 2.05e-03 | 9 | 144 | 2 | IPR029016 | |
| Domain | PD | 2.05e-03 | 9 | 144 | 2 | SM00018 | |
| Domain | JmjC | 2.07e-03 | 33 | 144 | 3 | SM00558 | |
| Domain | GST_CTER | 2.25e-03 | 34 | 144 | 3 | PS50405 | |
| Domain | MIR | 2.55e-03 | 10 | 144 | 2 | PF02815 | |
| Domain | JmjN | 2.55e-03 | 10 | 144 | 2 | SM00545 | |
| Domain | MIR_motif | 2.55e-03 | 10 | 144 | 2 | IPR016093 | |
| Domain | JmjN | 2.55e-03 | 10 | 144 | 2 | PF02375 | |
| Domain | MIR | 2.55e-03 | 10 | 144 | 2 | PS50919 | |
| Domain | MIR | 2.55e-03 | 10 | 144 | 2 | SM00472 | |
| Domain | JMJN | 2.55e-03 | 10 | 144 | 2 | PS51183 | |
| Domain | JmjN | 2.55e-03 | 10 | 144 | 2 | IPR003349 | |
| Domain | GST_C_3 | 2.55e-03 | 10 | 144 | 2 | PF14497 | |
| Domain | BROMODOMAIN_1 | 2.88e-03 | 37 | 144 | 3 | PS00633 | |
| Pathway | KEGG_PURINE_METABOLISM | 5.62e-05 | 159 | 118 | 8 | M14314 | |
| Pathway | WP_PURINE_METABOLISM | 9.38e-05 | 171 | 118 | 8 | MM15909 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 9.40e-05 | 55 | 118 | 5 | M39763 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION | 1.23e-04 | 31 | 118 | 4 | M496 | |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION | 1.23e-04 | 31 | 118 | 4 | MM15427 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.24e-04 | 178 | 118 | 8 | M2890 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.33e-04 | 147 | 118 | 7 | MM15854 | |
| Pubmed | KDELR3 RPL30 RAB11B DENND4A KDM5A DSP PCDHGA11 PCDHGA3 PPP1R9A RAB11A GRIA1 HMGCL NEB SMC2 YWHAB RYR2 ABCB4 PHEX PARP1 TRAP1 CTR9 SNX25 DLG2 DLG3 STAG2 TOP2A PCID2 | 7.34e-11 | 1442 | 147 | 27 | 35575683 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RAB11B GALNT2 LUC7L3 DSP PPP1R9A DARS1 SPECC1L SMC2 YWHAB ITPR2 PARP1 TRAP1 TXNDC5 AIFM1 GLO1 DOCK7 ZNF638 MRTO4 STIP1 HSPA4 STAG2 TOP2A | 4.16e-10 | 1024 | 147 | 22 | 24711643 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 RPL30 ERCC3 SETD1B DSP USP11 RANBP9 PTPN23 DARS1 SMC2 YWHAB TGM3 PARP1 AIFM1 CTR9 PRIM2 ZNF638 POLR1B MRTO4 SCFD1 HSPA4 SDC1 TOP2A PCID2 | 2.76e-09 | 1353 | 147 | 24 | 29467282 |
| Pubmed | RPL30 RAB11B KDM5A DSP USP11 RAB11A RANBP9 DARS1 SMC2 YWHAB GSTM1 GSTM2 GSTM4 TGM3 PARP1 TRAP1 ASAP2 TXNDC5 CTR9 EXOG SCFD1 HSPA4 | 3.68e-09 | 1153 | 147 | 22 | 29845934 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RPL30 ADCY4 DENND4A LUC7L3 DSP RAB11A DARS1 HMGCL SMC2 TGM3 PARP1 TRAP1 TXNDC5 AIFM1 CTR9 GLO1 DOCK7 MRTO4 STIP1 SCFD1 HSPA4 STAG2 TOP2A MGAM2 | 7.53e-09 | 1425 | 147 | 24 | 30948266 |
| Pubmed | ILDR2 RPL30 ADCY4 DSP PPP1R9A PSD3 GRIA1 DARS1 SRGAP2 SPECC1L ITGA2 YWHAB ITPR2 GSTM1 PTK2B PARP1 SLC24A2 GLO1 FTH1 DOCK7 DLG2 DLG3 STIP1 HSPA4 | 8.16e-09 | 1431 | 147 | 24 | 37142655 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RAB11B DSP RAB11A DARS1 YWHAB GSTM4 PARP1 FSD1L TRAP1 TXNDC5 AIFM1 GLO1 BRPF1 NT5C2 STIP1 HSPA4 DISP1 ALG13 | 1.04e-08 | 807 | 147 | 18 | 30575818 |
| Pubmed | EHBP1 DSP RANBP9 PTPN23 SPECC1L NEB YWHAB PROM1 ASAP2 ARHGEF9 FTH1 VAV3 PIBF1 SOS2 | 2.20e-08 | 486 | 147 | 14 | 20936779 | |
| Pubmed | 7.40e-08 | 3 | 147 | 3 | 16549767 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RPL30 LUC7L3 DSP RAB11A RANBP9 PTPN23 DARS1 SRGAP2 SMC2 YWHAB ISY1 PARP1 TXNDC5 AIFM1 CTR9 PRIM2 ZNF638 MRTO4 STIP1 HSPA4 STAG2 TOP2A | 1.37e-07 | 1415 | 147 | 22 | 28515276 |
| Pubmed | 2.95e-07 | 4 | 147 | 3 | 22406107 | ||
| Pubmed | 2.95e-07 | 4 | 147 | 3 | 8373352 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPL30 RAB11B LUC7L3 DSP USP11 RANBP9 NAA10 DARS1 SRGAP2 SMC2 YWHAB PARP1 TRAP1 TXNDC5 GLO1 DOCK7 STIP1 SCFD1 HSPA4 | 4.24e-07 | 1149 | 147 | 19 | 35446349 |
| Pubmed | RAB11A PTPN23 DARS1 SMC2 PARP1 TRAP1 TXNDC5 AIFM1 CTR9 PRIM2 STIP1 SCFD1 HSPA4 STAG2 | 6.03e-07 | 638 | 147 | 14 | 33239621 | |
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 18551009 | ||
| Pubmed | 7.35e-07 | 5 | 147 | 3 | 19856098 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RPL30 RAB11B GALNT2 PDGFRA PHLDA1 DSP CYBC1 PTPN23 DARS1 HMGCL GMPR2 YWHAB USP20 TGM3 TRAP1 TXNDC5 AIFM1 FTH1 NT5C2 MYDGF SCFD1 | 8.68e-07 | 1451 | 147 | 21 | 30550785 |
| Pubmed | 1.47e-06 | 6 | 147 | 3 | 1530570 | ||
| Pubmed | DENND4A KDM5A DSP USP11 NEB JMJD1C MTMR14 FTH1 MRTO4 STIP1 STAG2 PLCE1 | 1.49e-06 | 497 | 147 | 12 | 23414517 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DENND4A LUC7L3 DSP WEE1 USP11 RAB11A RANBP9 SRGAP2 SMC2 YWHAB JMJD1C RGS10 ASAP2 LOXHD1 CCDC82 AIFM1 DLG3 STIP1 PCID2 | 2.20e-06 | 1284 | 147 | 19 | 17353931 |
| Pubmed | EHBP1 RAB11B ITGA2 BBS5 GMPR2 NEB TTF1 USP20 ITPR2 FSD1L CCDC82 CTR9 ARHGEF9 NT5C2 ZNF638 MRTO4 MCOLN3 PCID2 ALG13 | 2.43e-06 | 1293 | 147 | 19 | 15342556 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ERCC3 SETD1B WEE1 USP11 ITPR2 PARP1 AIFM1 CTR9 POLR1B HSPA4 TOP2A | 2.97e-06 | 440 | 147 | 11 | 34244565 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NAT1 RPL30 LUC7L3 KDM5A NAA10 DARS1 SMC2 TTF1 PARP1 TRAP1 AIFM1 CTR9 POLR1B MRTO4 STIP1 SCFD1 HSPA4 TOP2A PCID2 | 3.21e-06 | 1318 | 147 | 19 | 30463901 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 3.36e-06 | 281 | 147 | 9 | 28706196 | |
| Pubmed | KDM5A PPP1R9A RANBP9 GRIA1 SRGAP2 SPECC1L SMC2 YWHAB PARP1 DOCK7 NT5C2 DLG2 DLG3 STIP1 EXOG SMG6 | 3.49e-06 | 963 | 147 | 16 | 28671696 | |
| Pubmed | LUC7L3 DSP USP11 RANBP9 DARS1 YWHAB PARP1 TXNDC5 MTMR14 AIFM1 HSPA4 ALG13 | 4.29e-06 | 551 | 147 | 12 | 34728620 | |
| Pubmed | ERCC3 SRGAP2 SPECC1L YWHAB PARP1 TXNDC5 AIFM1 CTR9 DOCK7 POLR1B MRTO4 TOP2A PCID2 | 5.02e-06 | 660 | 147 | 13 | 32780723 | |
| Pubmed | 5.40e-06 | 224 | 147 | 8 | 32941674 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 KDM5A DSP WEE1 TBC1D9 ZBTB7A FAM13A CTR9 BRPF1 FTH1 ZNF638 SCFD1 STAG2 TOP2A | 5.67e-06 | 774 | 147 | 14 | 15302935 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | EHBP1 RAB11B LRRC57 PHLDA1 PPP1R9A PSD3 ITGA2 ADCY9 PROM1 DOCK7 DLG3 SDC1 | 5.94e-06 | 569 | 147 | 12 | 30639242 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL30 ERCC3 DSP DARS1 SPECC1L SMC2 YWHAB ISY1 ITPR2 GSTM1 GSTM2 TGM3 PARP1 DOCK7 ZNF638 POLR1B MRTO4 TOP2A | 6.51e-06 | 1257 | 147 | 18 | 36526897 |
| Pubmed | RANBP9 SRGAP2 TGM3 ASAP2 TXNDC5 FAM13A MTMR14 GLO1 BRPF1 ARHGEF9 DOCK7 NT5C2 VAV3 STIP1 SOS2 | 8.51e-06 | 916 | 147 | 15 | 32203420 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 9.85e-06 | 67 | 147 | 5 | 21875946 | |
| Pubmed | DSP PPP1R9A PSD3 PTPN23 YWHAB ADCY9 ITPR2 PARP1 TXNDC5 MTMR14 AIFM1 CTR9 PRIM2 ZNF638 STIP1 PIBF1 | 1.02e-05 | 1049 | 147 | 16 | 27880917 | |
| Pubmed | EHBP1 DSP PSD3 PTPN23 DARS1 SMC2 JMJD1C ADCY9 PARP1 AIFM1 DOCK7 STIP1 HSPA4 | 1.06e-05 | 708 | 147 | 13 | 39231216 | |
| Pubmed | RPL30 GALNT2 LUC7L3 RANBP9 SPECC1L SMC2 YWHAB ITPR2 PARP1 TRAP1 AIFM1 DOCK7 MRTO4 STIP1 SCFD1 HSPA4 STAG2 RAB27A TOP2A | 1.13e-05 | 1440 | 147 | 19 | 30833792 | |
| Pubmed | Haploinsufficiency in the ANKS1B gene encoding AIDA-1 leads to a neurodevelopmental syndrome. | 1.19e-05 | 11 | 147 | 3 | 31388001 | |
| Pubmed | RPL30 USP11 RANBP9 DARS1 SPECC1L YWHAB ISY1 GSTM2 PARP1 TRAP1 TXNDC5 AIFM1 GLO1 PRIM2 ZNF638 STIP1 SCFD1 HSPA4 | 1.46e-05 | 1335 | 147 | 18 | 29229926 | |
| Pubmed | RPL30 LUC7L3 DSP DARS1 SMC2 ISY1 PARP1 TRAP1 AIFM1 CTR9 MRTO4 TOP2A PCID2 | 1.48e-05 | 731 | 147 | 13 | 29298432 | |
| Pubmed | 1.71e-05 | 75 | 147 | 5 | 25593309 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 19246321 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 26085644 | ||
| Pubmed | Structure of human glutathione S-transferase class Mu genes. | 1.77e-05 | 2 | 147 | 2 | 2006920 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 3174634 | ||
| Pubmed | PARP-1 regulates mouse embryonic neural stem cell proliferation by regulating PDGFRα expression. | 1.77e-05 | 2 | 147 | 2 | 32295715 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24048194 | ||
| Pubmed | AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration. | 1.77e-05 | 2 | 147 | 2 | 28055012 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 10775038 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 12486119 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 22049795 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24399650 | ||
| Pubmed | Mitochondrial calcium overload is a key determinant in heart failure. | 1.77e-05 | 2 | 147 | 2 | 26217001 | |
| Pubmed | A role for Rab11 in the homeostasis of the endosome-lysosomal pathway. | 1.77e-05 | 2 | 147 | 2 | 30981667 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 23675469 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 15729291 | ||
| Pubmed | SDC1 and ITGA2 as novel prognostic biomarkers for PDAC related to IPMN. | 1.77e-05 | 2 | 147 | 2 | 37907515 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 30038560 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 21124852 | ||
| Pubmed | Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities. | 1.77e-05 | 2 | 147 | 2 | 24684389 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 6500576 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28158491 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 33168626 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 17700360 | ||
| Pubmed | Cloning and expression of a novel Mu class murine glutathione transferase isoenzyme. | 1.77e-05 | 2 | 147 | 2 | 12069689 | |
| Pubmed | Calcium dynamics change in degenerating cone photoreceptors. | 1.77e-05 | 2 | 147 | 2 | 27402880 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 12900584 | ||
| Pubmed | Prominin 1 is crucial for the early development of photoreceptor outer segments. | 1.77e-05 | 2 | 147 | 2 | 38714794 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 31710697 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 12084015 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 12192076 | ||
| Pubmed | Rab11b regulates the trafficking and recycling of the epithelial sodium channel (ENaC). | 1.77e-05 | 2 | 147 | 2 | 22129970 | |
| Pubmed | RAB11A and RAB11B control mitotic spindle function in intestinal epithelial progenitor cells. | 1.77e-05 | 2 | 147 | 2 | 37424454 | |
| Pubmed | Heat shock protein-70 neutralizes apoptosis inducing factor in Bcr/Abl expressing cells. | 1.77e-05 | 2 | 147 | 2 | 26165468 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24356817 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EHBP1 DENND4A PDGFRA KDM5A DSP WEE1 PSD3 NAA10 SRGAP2 YWHAB PTK2B FAM13A DOCK7 PIBF1 | 1.86e-05 | 861 | 147 | 14 | 36931259 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | EHBP1 RPL30 RAB11B LUC7L3 USP11 YWHAB ADCY9 ITPR2 PARP1 TRAP1 AIFM1 GLO1 MRTO4 STIP1 EXOG SCFD1 TOP2A SMG6 ALG13 | 1.91e-05 | 1496 | 147 | 19 | 32877691 |
| Pubmed | 2.05e-05 | 13 | 147 | 3 | 28482867 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL30 LUC7L3 PDGFRA DSP YWHAB JMJD1C PARP1 TRAP1 TXNDC5 CTR9 ZNF638 MRTO4 CLSPN HSPA4 TOP2A | 2.08e-05 | 989 | 147 | 15 | 36424410 |
| Pubmed | PHLDA1 KDM5A WEE1 USP11 CECR2 RANBP9 ADCY9 ISY1 ZBTB7A SAT1 BRDT BRPF1 CLSPN TOP2A PCID2 ALG13 | 2.17e-05 | 1116 | 147 | 16 | 31753913 | |
| Pubmed | UBR1 RPL30 DENND4A GALNT2 LUC7L3 SMC2 JMJD1C CTR9 DOCK7 ZNF638 CLSPN PLCE1 | 2.22e-05 | 650 | 147 | 12 | 38777146 | |
| Pubmed | UBR1 RPL30 ERCC3 RAB11A RANBP9 DARS1 SPECC1L SMC2 YWHAB ISY1 PARP1 TXNDC5 AIFM1 STIP1 HSPA4 TOP2A PCID2 | 2.24e-05 | 1247 | 147 | 17 | 27684187 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | DSP PCDHGA11 ANXA13 ITGA2 GLB1L2 GMPR2 TBC1D9 TRANK1 LOXHD1 NT5C2 ITPRIP | 2.47e-05 | 552 | 147 | 11 | 10737800 |
| Pubmed | EHBP1 DSP RANBP9 PSD3 GRIA1 DARS1 HMGCL RYR2 GSTM1 TRAP1 TXNDC5 SNX25 DOCK7 DLG2 DLG3 STIP1 | 2.77e-05 | 1139 | 147 | 16 | 36417873 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | 3.31e-05 | 288 | 147 | 8 | 31501420 | |
| Pubmed | 3.31e-05 | 288 | 147 | 8 | 23383273 | ||
| Pubmed | RPL30 DSP RAB11A DARS1 SMC2 YWHAB PARP1 TRAP1 TXNDC5 STIP1 HSPA4 TOP2A SOS2 | 3.92e-05 | 803 | 147 | 13 | 36517590 | |
| Pubmed | A brain atlas of synapse protein lifetime across the mouse lifespan. | 5.31e-05 | 3 | 147 | 2 | 36202095 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 18262724 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 16842493 | ||
| Pubmed | PTRF/Cavin-1 promotes efficient ribosomal RNA transcription in response to metabolic challenges. | 5.31e-05 | 3 | 147 | 2 | 27528195 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 30440055 | ||
| Pubmed | Naa12 compensates for Naa10 in mice in the amino-terminal acetylation pathway. | 5.31e-05 | 3 | 147 | 2 | 34355692 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 8512323 | ||
| Pubmed | Association between the DOCK7, PCSK9 and GALNT2 Gene Polymorphisms and Serum Lipid levels. | 5.31e-05 | 3 | 147 | 2 | 26744084 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 38854587 | ||
| Pubmed | Small Extracellular Vesicles Have GST Activity and Ameliorate Senescence-Related Tissue Damage. | 5.31e-05 | 3 | 147 | 2 | 32574561 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 26493351 | ||
| Pubmed | Syndecan- and integrin-binding peptides synergistically accelerate cell adhesion. | 5.31e-05 | 3 | 147 | 2 | 20598296 | |
| Pubmed | PARP-1-modulated AIF translocation is involved in streptomycin-induced cochlear hair cell death. | 5.31e-05 | 3 | 147 | 2 | 26963167 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 9452477 | ||
| Cytoband | 1p13.3 | 7.42e-05 | 69 | 147 | 4 | 1p13.3 | |
| Cytoband | 1q41-q42 | 1.01e-04 | 5 | 147 | 2 | 1q41-q42 | |
| Cytoband | 12p11 | 3.61e-04 | 9 | 147 | 2 | 12p11 | |
| Cytoband | 14q12 | 7.47e-04 | 55 | 147 | 3 | 14q12 | |
| Cytoband | 2q21.3 | 1.04e-03 | 15 | 147 | 2 | 2q21.3 | |
| Cytoband | 5q31.1 | 1.11e-03 | 63 | 147 | 3 | 5q31.1 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.24e-04 | 24 | 102 | 3 | 485 | |
| GeneFamily | GCN5 related N-acetyltransferases | 3.24e-04 | 24 | 102 | 3 | 1134 | |
| GeneFamily | Glutathione S-transferases | 3.66e-04 | 25 | 102 | 3 | 567 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.38e-03 | 10 | 102 | 2 | 53 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 2.00e-03 | 12 | 102 | 2 | 660 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EHBP1 KDM5A KDM4C PSD3 SRGAP2 SPECC1L TRAPPC8 ADCY9 ASAP2 PRIM2 NT5C2 ZNF638 PIBF1 STAG2 TOP2A PLCE1 SOS2 | 6.61e-06 | 856 | 147 | 17 | M4500 |
| Coexpression | GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP | 1.74e-05 | 199 | 147 | 8 | M9220 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | UBR1 RPL30 DENND4A PHLDA1 KDM5A CYBC1 RANBP9 DARS1 TRAPPC8 YWHAB JMJD1C RGS10 USP20 ITPR2 PTK2B PARP1 TRANK1 GLO1 ZNF638 VAV3 STAG2 RAB27A | 3.07e-05 | 1492 | 147 | 22 | M40023 |
| Coexpression | PUJANA_ATM_PCC_NETWORK | NAT1 RPL30 ERCC3 GALNT2 ANXA13 RANBP9 GRIA1 DARS1 SMC2 YWHAB RGS10 PARP1 CTR9 NT5C2 EXOG SCFD1 PIBF1 HSPA4 STAG2 ALOX5 TOP2A | 3.48e-05 | 1394 | 147 | 21 | M9585 |
| Coexpression | AIZARANI_LIVER_C8_RESIDENT_B_CELLS_1 | 4.34e-05 | 35 | 147 | 4 | M39112 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | GALNT2 PTPN23 HMGCL SRGAP2 ITPR2 GSTM1 PTK2B FSD1L TRAP1 ARHGEF9 FTH1 ITPRIP PPP2R3C ALOX5 RAB27A PCID2 | 8.18e-05 | 942 | 147 | 16 | M8144 |
| Coexpression | PARENT_MTOR_SIGNALING_UP | KDM5A ANXA13 RANBP9 HMGCL SRGAP2 ADCY9 TRANK1 FAM13A AIFM1 PRIM2 FLRT1 HSPA4 | 8.88e-05 | 567 | 147 | 12 | M16909 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | NAT1 ERCC3 WEE1 ANXA13 NAA10 DARS1 SMC2 TTF1 YWHAB PARP1 CTR9 EXOG HSPA4 TOP2A | 1.02e-04 | 761 | 147 | 14 | M11961 |
| Coexpression | EGFR_UP.V1_UP | 1.09e-04 | 192 | 147 | 7 | M2634 | |
| Coexpression | GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN | 1.12e-04 | 134 | 147 | 6 | M1896 | |
| Coexpression | WONG_EMBRYONIC_STEM_CELL_CORE | 1.20e-04 | 335 | 147 | 9 | M7079 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP | 1.32e-04 | 198 | 147 | 7 | M8036 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN | 1.32e-04 | 198 | 147 | 7 | M6731 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_DN | 1.36e-04 | 199 | 147 | 7 | M4558 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN | 1.36e-04 | 199 | 147 | 7 | M3836 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP | 1.40e-04 | 200 | 147 | 7 | M4613 | |
| Coexpression | GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP | 1.40e-04 | 200 | 147 | 7 | M9456 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN | 1.40e-04 | 200 | 147 | 7 | M4529 | |
| Coexpression | GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP | 1.40e-04 | 200 | 147 | 7 | M7489 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.40e-04 | 200 | 147 | 7 | M5216 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_200 | 2.01e-05 | 49 | 144 | 5 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k2_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 5.09e-05 | 192 | 144 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | ILDR2 NAA11 NEB GDF9 RYR2 GSTM1 GSTM2 PHEX MTMR14 BRDT ALG13 | 5.70e-05 | 379 | 144 | 11 | gudmap_developingGonad_P2_ovary_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | EPHB3 KDELR3 DENND4A USP11 PPP1R9A PSD3 GLB1L2 NEB TTF1 GSTM2 PROM1 NT5C2 CLSPN RAB27A | 7.68e-05 | 614 | 144 | 14 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_200 | 1.01e-04 | 36 | 144 | 4 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k3_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#3_top-relative-expression-ranked_100 | 1.13e-04 | 37 | 144 | 4 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k3_100 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.77e-09 | 179 | 147 | 9 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.55e-07 | 192 | 147 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.66e-07 | 193 | 147 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-07 | 195 | 147 | 8 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-07 | 195 | 147 | 8 | e87b11e3242fdbed2e7f383e6876ec375af32bd4 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-06 | 164 | 147 | 7 | 5621c2e3fae84d5a2e4f1595e454bcb3a2b3f93c | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.85e-06 | 174 | 147 | 7 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.15e-06 | 178 | 147 | 7 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.41e-06 | 181 | 147 | 7 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.50e-06 | 182 | 147 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 183 | 147 | 7 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 183 | 147 | 7 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 184 | 147 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 184 | 147 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-06 | 184 | 147 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 3.20e-06 | 189 | 147 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.94e-06 | 195 | 147 | 7 | 533818e89d809f01fbb5c4b57932b76aa5c8f30e | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.21e-06 | 197 | 147 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.35e-06 | 198 | 147 | 7 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.35e-06 | 198 | 147 | 7 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.65e-06 | 200 | 147 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.11e-05 | 151 | 147 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.24e-05 | 154 | 147 | 6 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.33e-05 | 156 | 147 | 6 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.33e-05 | 156 | 147 | 6 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.71e-05 | 163 | 147 | 6 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.17e-05 | 170 | 147 | 6 | c5b87974dfddf9780051f7f5693eeeb0c606a3fe | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.39e-05 | 173 | 147 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-05 | 173 | 147 | 6 | e0cf99ddbe6e9eab05d7bf89e9aa124850c6a807 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.47e-05 | 174 | 147 | 6 | 94575a605c725de83f66a6cf7df9d7bb360ffc56 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.47e-05 | 174 | 147 | 6 | 40c81ab36d7931e271e20d7d56fed32463c75f41 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.47e-05 | 174 | 147 | 6 | b8d1c556290d188f56aeefc17f03119686945fe7 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.47e-05 | 174 | 147 | 6 | b43fb0fbb492c1be6e791a1c4d6c4e5956955ee4 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.47e-05 | 174 | 147 | 6 | 00cf27bc23af1472a507be31fba6245a8fdd901b | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 175 | 147 | 6 | 4be01bf30331162f1998216fb2871a4e626dc440 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-05 | 176 | 147 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 177 | 147 | 6 | 35d42b07d9c31528bf59199e361bb8a3bfbe3b75 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 2.81e-05 | 178 | 147 | 6 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 179 | 147 | 6 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-05 | 179 | 147 | 6 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 181 | 147 | 6 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 181 | 147 | 6 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 183 | 147 | 6 | b0b835f3b1de1bd46a47e1b805aa8994cd3a4e3e | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 183 | 147 | 6 | ffb1bbbccb34d1a7e99872611f497450039d5019 | |
| ToppCell | Serous|World / shred by cell class for bronchial biopsy | 3.38e-05 | 184 | 147 | 6 | 09d0d1525c11dd326efd942684c03f79d992cf3b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-05 | 184 | 147 | 6 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-05 | 185 | 147 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.48e-05 | 185 | 147 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.48e-05 | 185 | 147 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.59e-05 | 186 | 147 | 6 | 708c5edefe36c91df27cf53c1b5101fb2030cc5a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-F_(Ciliated)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.59e-05 | 186 | 147 | 6 | 029390c4aaf64e6bcd86124cd4a6dd2e6f3a374b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.70e-05 | 187 | 147 | 6 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 3.81e-05 | 188 | 147 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.81e-05 | 188 | 147 | 6 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 189 | 147 | 6 | 45b9d00a4968fb22207d95228cdcf022afe1e50b | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 189 | 147 | 6 | 8382d331e01e83591ba9c8ea83edbf2436c18b17 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.93e-05 | 189 | 147 | 6 | 886dceacf96e2b6750c146a381da0bf96a2bb15b | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 3.93e-05 | 189 | 147 | 6 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.93e-05 | 189 | 147 | 6 | 5f1f4321939877374a8ee13de93f2d1390af8e2e | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.04e-05 | 190 | 147 | 6 | a21d0c574abf21e7cb865a21a48f29c92d055fbe | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.04e-05 | 190 | 147 | 6 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | BL-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.16e-05 | 191 | 147 | 6 | 3f9b8c4fb72ae6f3167b187e6715c4dcb3159f98 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.16e-05 | 191 | 147 | 6 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.16e-05 | 191 | 147 | 6 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.16e-05 | 191 | 147 | 6 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.41e-05 | 193 | 147 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.54e-05 | 194 | 147 | 6 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.54e-05 | 194 | 147 | 6 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.67e-05 | 195 | 147 | 6 | 07852aab50a2ece9938334301f0a9d7181da06b8 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 4.67e-05 | 195 | 147 | 6 | 1390728b9a514db534e8bc6dcf72cf51a1065780 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.81e-05 | 196 | 147 | 6 | 5e5928fc218859317860fc387928127ac8009ba8 | |
| ToppCell | FLU-Healthy-2|FLU / Virus stimulation, Condition and Cluster | 4.81e-05 | 196 | 147 | 6 | 0f2240a64a1cdd3147f2330f51c871cd0df8c055 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 4.95e-05 | 197 | 147 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Severe|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.95e-05 | 197 | 147 | 6 | df3f58b58f82c42c65b0a09c054b669b34502037 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 4.95e-05 | 197 | 147 | 6 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.09e-05 | 198 | 147 | 6 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.09e-05 | 198 | 147 | 6 | 19d8ff3a4f911b13ecc34844202925475ad4d2ab | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.23e-05 | 199 | 147 | 6 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.23e-05 | 199 | 147 | 6 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.38e-05 | 200 | 147 | 6 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.38e-05 | 200 | 147 | 6 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 200 | 147 | 6 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 5.38e-05 | 200 | 147 | 6 | b0d708715f09ec1f67fdef3b100a91c8ff2747a7 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 5.38e-05 | 200 | 147 | 6 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 200 | 147 | 6 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Granulocytic_cells-Mast-cells|LPS_only / Treatment groups by lineage, cell group, cell type | 5.38e-05 | 200 | 147 | 6 | afbbfe0b8e66df36c244935182cb26feeb31a085 | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.87e-05 | 136 | 147 | 5 | 82d7f90ef2a63a3137c331efd68c036cd0db3ac1 | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Platelets|LPS_only / Treatment groups by lineage, cell group, cell type | 9.51e-05 | 138 | 147 | 5 | 6ddd50e44a3914596b4cd61ae64a987119fe7979 | |
| ToppCell | normal_Lung-Myeloid_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 1.45e-04 | 151 | 147 | 5 | 23b6cf9a36ad0e937f69c75921bddd305a9a526c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 153 | 147 | 5 | 4eb9c2d7e4b95d44198fc87dc115a08ef0153e26 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 153 | 147 | 5 | 26b5b45c117d155b028d298a0b93e16d343dca97 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.54e-04 | 153 | 147 | 5 | 0f12e38f2cbf69a520764289b0aa4dedc645f714 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 155 | 147 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 155 | 147 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.79e-04 | 158 | 147 | 5 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.79e-04 | 158 | 147 | 5 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.79e-04 | 158 | 147 | 5 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-04 | 159 | 147 | 5 | e9c51e611ebd427bbe51e3e036c14122c36ea372 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-04 | 162 | 147 | 5 | a957c7e347189b72fbd47db3075bb5e879a21c67 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.19e-04 | 165 | 147 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| Drug | EUK-189 | 2.63e-06 | 16 | 144 | 4 | ctd:C436526 | |
| Drug | hexylglutathione | 4.89e-06 | 6 | 144 | 3 | ctd:C033550 | |
| Drug | 5149715; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 5.11e-06 | 199 | 144 | 9 | 890_UP | |
| Drug | Cibacron Blue F 3GA | 8.51e-06 | 7 | 144 | 3 | ctd:C012842 | |
| Disease | mean platelet volume | SETD1B GALNT2 PCDHGA11 PCDHGA3 PSD3 TENT5C ITGA2 YWHAB JMJD1C GSTM1 GSTM2 TRANK1 FAM13A CTR9 DOCK7 ITPRIP DLG3 STIP1 PLCE1 | 3.84e-07 | 1020 | 140 | 19 | EFO_0004584 |
| Disease | Brugada syndrome (implicated_via_orthology) | 1.04e-06 | 5 | 140 | 3 | DOID:0050451 (implicated_via_orthology) | |
| Disease | melanoma | 3.05e-06 | 248 | 140 | 9 | C0025202 | |
| Disease | mean corpuscular hemoglobin concentration | RAB11B DENND4A SETD1B GALNT2 RAB11A PSD3 TENT5C GMPR2 NEB ADCY9 ITPR2 BRDT FTH1 NT5C2 ZNF638 MYDGF CLSPN PIBF1 | 5.23e-06 | 1105 | 140 | 18 | EFO_0004528 |
| Disease | Intellectual Disability | RAB11B KDM5A RAB11A GRIA1 PTPN23 HMGCL SPECC1L PARP1 NT5C2 STAG2 ALG13 | 1.00e-05 | 447 | 140 | 11 | C3714756 |
| Disease | free cholesterol to total lipids in medium LDL percentage | 1.26e-05 | 63 | 140 | 5 | EFO_0022283 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 1.97e-05 | 69 | 140 | 5 | EFO_0022341 | |
| Disease | level of glutathione S-transferase mu 1 in blood serum | 2.24e-05 | 2 | 140 | 2 | OBA_2041806 | |
| Disease | Ogden syndrome (implicated_via_orthology) | 2.24e-05 | 2 | 140 | 2 | DOID:0050781 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in large LDL percentage | 2.77e-05 | 74 | 140 | 5 | EFO_0022280 | |
| Disease | docosahexaenoic acid measurement | 3.31e-05 | 127 | 140 | 6 | EFO_0007761 | |
| Disease | Degenerative Diseases, Central Nervous System | 3.51e-05 | 39 | 140 | 4 | C0270715 | |
| Disease | Neurodegenerative Disorders | 3.51e-05 | 39 | 140 | 4 | C0524851 | |
| Disease | Degenerative Diseases, Spinal Cord | 3.51e-05 | 39 | 140 | 4 | C0751733 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 9.20e-05 | 95 | 140 | 5 | EFO_0803331 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 9.44e-05 | 50 | 140 | 4 | EFO_0022303 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 1.02e-04 | 51 | 140 | 4 | EFO_0022302 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 1.19e-04 | 53 | 140 | 4 | EFO_0022286 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 1.31e-04 | 21 | 140 | 3 | EFO_0022262 | |
| Disease | head and neck cancer (is_implicated_in) | 1.33e-04 | 4 | 140 | 2 | DOID:11934 (is_implicated_in) | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 1.47e-04 | 56 | 140 | 4 | EFO_0022316 | |
| Disease | Malignant mesothelioma | 1.76e-04 | 109 | 140 | 5 | C0345967 | |
| Disease | monocyte count | DENND4A CECR2 RAB11A TENT5C DARS1 ADCY9 GSTM1 GSTM2 PTK2B MYDGF POLR1B STIP1 HSPA4 DISP1 MAP3K19 PLCE1 SMG6 | 1.79e-04 | 1320 | 140 | 17 | EFO_0005091 |
| Disease | triglycerides to total lipids in small LDL percentage | 1.80e-04 | 59 | 140 | 4 | EFO_0022337 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 1.80e-04 | 59 | 140 | 4 | EFO_0022260 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 1.93e-04 | 60 | 140 | 4 | EFO_0021898 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 2.19e-04 | 62 | 140 | 4 | EFO_0022339 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 2.19e-04 | 62 | 140 | 4 | EFO_0022306 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 2.19e-04 | 62 | 140 | 4 | EFO_0022263 | |
| Disease | medulloblastoma (is_marker_for) | 2.21e-04 | 5 | 140 | 2 | DOID:0050902 (is_marker_for) | |
| Disease | immunoglobulin superfamily DCC subclass member 4 measurement | 2.21e-04 | 5 | 140 | 2 | EFO_0801690 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 2.33e-04 | 63 | 140 | 4 | EFO_0022239 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 2.33e-04 | 63 | 140 | 4 | EFO_0022292 | |
| Disease | fatty acid measurement | 2.46e-04 | 436 | 140 | 9 | EFO_0005110 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 2.47e-04 | 64 | 140 | 4 | EFO_0022253 | |
| Disease | 1,5 anhydroglucitol measurement | 3.49e-04 | 29 | 140 | 3 | EFO_0008009 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 4.54e-04 | 75 | 140 | 4 | EFO_0022287 | |
| Disease | neuropilin-1 measurement | 4.62e-04 | 7 | 140 | 2 | EFO_0020603 | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 4.69e-04 | 32 | 140 | 3 | EFO_0021870 | |
| Disease | retinal degeneration (implicated_via_orthology) | 5.14e-04 | 33 | 140 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 5.27e-04 | 78 | 140 | 4 | EFO_0022187 | |
| Disease | triglyceride measurement, physical activity | 5.62e-04 | 34 | 140 | 3 | EFO_0003940, EFO_0004530 | |
| Disease | total lipids in small HDL measurement | 6.12e-04 | 35 | 140 | 3 | EFO_0022311 | |
| Disease | benign neoplasm (implicated_via_orthology) | 6.14e-04 | 8 | 140 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 7.41e-04 | 616 | 140 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 7.41e-04 | 616 | 140 | 10 | C0376358 | |
| Disease | memory performance | 7.75e-04 | 409 | 140 | 8 | EFO_0004874 | |
| Disease | phospholipids in small HDL measurement | 7.81e-04 | 38 | 140 | 3 | EFO_0022296 | |
| Disease | 5-acetylamino-6-formylamino-3-methyluracil measurement | 7.87e-04 | 9 | 140 | 2 | EFO_0800950 | |
| Disease | cholestasis (implicated_via_orthology) | 7.87e-04 | 9 | 140 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | Glioma | 7.96e-04 | 87 | 140 | 4 | C0017638 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 8.34e-04 | 153 | 140 | 5 | EFO_0004611, EFO_0020946 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 8.84e-04 | 321 | 140 | 7 | EFO_0004612, EFO_0004639 | |
| Disease | docosahexaenoic acid measurement, fatty acid measurement | 9.08e-04 | 40 | 140 | 3 | EFO_0005110, EFO_0007761 | |
| Disease | Cutaneous Melanoma | 9.77e-04 | 41 | 140 | 3 | C0151779 | |
| Disease | alopecia areata (is_marker_for) | 9.81e-04 | 10 | 140 | 2 | DOID:986 (is_marker_for) | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 9.81e-04 | 10 | 140 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 1.04e-03 | 330 | 140 | 7 | EFO_0004529, EFO_0004612 | |
| Disease | autistic disorder (is_implicated_in) | 1.05e-03 | 42 | 140 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.11e-03 | 95 | 140 | 4 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.15e-03 | 96 | 140 | 4 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | 5-acetylamino-6-amino-3-methyluracil measurement | 1.20e-03 | 11 | 140 | 2 | EFO_0800951 | |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 1.20e-03 | 11 | 140 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | bilirubin measurement | 1.27e-03 | 442 | 140 | 8 | EFO_0004570 | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 1.28e-03 | 45 | 140 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | triglyceride measurement, alcohol drinking | 1.29e-03 | 99 | 140 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | aortic measurement | 1.30e-03 | 251 | 140 | 6 | EFO_0020865 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.39e-03 | 101 | 140 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | N-acetylputrescine measurement | 1.43e-03 | 12 | 140 | 2 | EFO_0800127 | |
| Disease | reticulocyte count | RAB11B DENND4A RAB11A TENT5C HMGCL JMJD1C ABCB4 NT5C2 FLRT1 HSPA4 ALOX5 PCID2 SMG6 | 1.45e-03 | 1045 | 140 | 13 | EFO_0007986 |
| Disease | erythrocyte measurement | 1.46e-03 | 257 | 140 | 6 | EFO_0005047 | |
| Disease | cholesteryl ester measurement | 1.46e-03 | 257 | 140 | 6 | EFO_0010351 | |
| Disease | Unipolar Depression | 1.52e-03 | 259 | 140 | 6 | C0041696 | |
| Disease | sleep duration, triglyceride measurement | 1.55e-03 | 104 | 140 | 4 | EFO_0004530, EFO_0005271 | |
| Disease | lipoprotein measurement | 1.60e-03 | 105 | 140 | 4 | EFO_0004732 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 1.64e-03 | 49 | 140 | 3 | EFO_0021897 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.66e-03 | 106 | 140 | 4 | EFO_0008317, EFO_0008596 | |
| Disease | salicylurate measurement | 1.68e-03 | 13 | 140 | 2 | EFO_0010532 | |
| Disease | myeloid leukemia (is_implicated_in) | 1.68e-03 | 13 | 140 | 2 | DOID:8692 (is_implicated_in) | |
| Disease | myeloid white cell count | SETD1B DARS1 JMJD1C PTK2B ZBTB7A TRAP1 FAM13A TTC29 POLR1B VAV3 PLCE1 SMG6 | 1.74e-03 | 937 | 140 | 12 | EFO_0007988 |
| Disease | diabetic retinopathy (is_implicated_in) | 1.74e-03 | 50 | 140 | 3 | DOID:8947 (is_implicated_in) | |
| Disease | gallstones | 1.78e-03 | 108 | 140 | 4 | EFO_0004210 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.84e-03 | 109 | 140 | 4 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.90e-03 | 110 | 140 | 4 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.90e-03 | 110 | 140 | 4 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.90e-03 | 110 | 140 | 4 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | Hamman-Rich syndrome | 1.96e-03 | 14 | 140 | 2 | C0085786 | |
| Disease | 1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement | 1.96e-03 | 14 | 140 | 2 | EFO_0022085 | |
| Disease | Glioblastoma Multiforme | 1.96e-03 | 111 | 140 | 4 | C1621958 | |
| Disease | Bipolar Disorder | 2.05e-03 | 477 | 140 | 8 | C0005586 | |
| Disease | plasminogen activator inhibitor 1 measurement | 2.17e-03 | 54 | 140 | 3 | EFO_0004792 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 2.25e-03 | 15 | 140 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | quinate measurement | 2.25e-03 | 15 | 140 | 2 | EFO_0021167 | |
| Disease | leukemia | 2.29e-03 | 55 | 140 | 3 | C0023418 | |
| Disease | phospholipids in medium HDL measurement | 2.29e-03 | 55 | 140 | 3 | EFO_0022295 | |
| Disease | triglycerides in large VLDL measurement | 2.41e-03 | 56 | 140 | 3 | EFO_0022178 | |
| Disease | triglycerides in LDL measurement | 2.41e-03 | 56 | 140 | 3 | EFO_0022320 | |
| Disease | triglycerides in very large VLDL measurement | 2.41e-03 | 56 | 140 | 3 | EFO_0022325 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.43e-03 | 195 | 140 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 2.45e-03 | 118 | 140 | 4 | EFO_0010119 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YKGRYSEGDTEKLKM | 616 | Q15361 | |
| GLRLIYFSYDVKMKE | 61 | A0A5B6 | |
| MDIEAYLERIGYKKS | 1 | P18440 | |
| YKFKLEDYMDGLAIR | 696 | Q86US8 | |
| LKMKGDYFRYLSEVA | 121 | P31946 | |
| YETSKMYRDFKLRSA | 131 | Q8N3I7 | |
| ILEVYYKSTEKSGMY | 51 | A8MTT3 | |
| FYVKAEDMEGKYSVA | 546 | Q96JP9 | |
| SRKELQKSDYMEYAG | 476 | Q9NP73 | |
| EYRKSYVRKAFMKLD | 516 | Q9BXY5 | |
| SDYKYTDKIMTYLFD | 251 | P49902 | |
| YKDAYKFAADVRLMF | 331 | Q58F21 | |
| GAYAYKTMKEDEKRY | 81 | O95831 | |
| SYVIDEDVKSGRYME | 476 | Q69YQ0 | |
| YFREKEMEKEYRLSA | 566 | Q8NFM4 | |
| CEDYFAERLYKSMKG | 246 | P27216 | |
| FERYDAEYKKLFMFE | 761 | Q96F81 | |
| RKYNGESSEYTKMSD | 511 | Q9BXF3 | |
| YYKGRIDMDKYEVVD | 361 | O43307 | |
| FDKEYKMAYDRLTPS | 1821 | Q7Z401 | |
| YFEVKIVSKGRDGYM | 216 | Q96S59 | |
| MGTRDDEYDYLFKVV | 1 | P62491 | |
| MGTRDDEYDYLFKVV | 1 | Q15907 | |
| MSDGDYDYLIKFLAL | 1 | P51159 | |
| NLMKYDSYSRFLKSD | 136 | O43665 | |
| SLYRKTLDSFYEMLK | 511 | Q8IWB1 | |
| GSLDFEKYRFYEMEI | 306 | Q9Y5H2 | |
| SYEAYEDLMKKSQEG | 661 | Q9H3S7 | |
| MAESSDKLYRVEYAK | 1 | P09874 | |
| TLFMKYSSYREDVLK | 221 | Q14571 | |
| YMLSIYKKEFGEDND | 991 | Q14571 | |
| LEGYDKYMERFTATK | 221 | Q8N9N7 | |
| YKKLKEEEMADTSYG | 406 | Q96EP9 | |
| ELKDEEMDLFTKYYS | 26 | Q969Q6 | |
| VDSTFYNKIKSGYRM | 901 | P16234 | |
| YEMRDKLSGEYEKFV | 626 | P34932 | |
| YSDIDYMDGKKDFTV | 366 | Q2M2H8 | |
| YMDGKKDFTVDEVAY | 371 | Q2M2H8 | |
| LFLKGYMDRMDDTYA | 101 | Q8TDD5 | |
| KEYKDRDYMAEGLIF | 256 | Q8NCE2 | |
| EYTLSGLKFDSKYMN | 261 | Q9BXM9 | |
| KTRAELMKAIDFEYY | 146 | Q9ULR0 | |
| GSDMNARKDYITAKY | 516 | O43150 | |
| KMKEEKYDYISRGEN | 326 | Q15652 | |
| FVMDKFYFEELGKYD | 311 | Q10471 | |
| PYDIFTEKYMKDGSL | 1226 | Q8IVV2 | |
| YMIYGKFRKTFDSEN | 76 | O43731 | |
| MKFSLYFLAYEDKND | 66 | Q04760 | |
| GKLKSYYTDLEAFAM | 576 | P35913 | |
| GRLKKYYTDLEAFAM | 581 | P51160 | |
| KYYADGEDAYAMKRD | 136 | P41227 | |
| LEYTDSSYEEKKYTM | 21 | P28161 | |
| KKYTMGDAPDYDRSQ | 31 | P28161 | |
| FREFNKYLAYMESKG | 26 | Q9H3R0 | |
| GVILDYEMKYFEKSE | 481 | P54753 | |
| YEMKYFEKSEGIAST | 486 | P54753 | |
| EKSSRFMKVGYERDF | 71 | O95232 | |
| KYKKVRFMAYTDETF | 441 | P00451 | |
| EIEPDDYFMSRYEKK | 336 | Q9Y2C4 | |
| DYFMSRYEKKLEELK | 341 | Q9Y2C4 | |
| IERDGKKYKLFYGMS | 256 | Q9P2T1 | |
| KEDRTPMAEEYSEYK | 986 | O94988 | |
| YMSDLKKEEGRVYLF | 516 | P17301 | |
| ETYGYDMKDTASVKS | 1351 | P29375 | |
| QERKFESMYVEKLYG | 911 | P21439 | |
| VSILKSLDYEDAMFY | 301 | Q9Y5H0 | |
| MDPDKFDKGYSYNIR | 336 | P49643 | |
| TYKYYVGRKAMFDSD | 211 | Q5JVF3 | |
| LSMSYYFDRDDVALK | 36 | P02794 | |
| YDGTRQKSYAKDMLT | 361 | Q8N4S0 | |
| VVTYKFKYEGMAVSE | 406 | O95393 | |
| DTYEMKDRITYFDKN | 1921 | Q96N67 | |
| GDYYRFLSEMLKSLE | 1011 | P15924 | |
| RYFSYLSKVGDKMRF | 791 | Q6PD62 | |
| SVEEEKVRYFGKGYM | 111 | Q9BQA9 | |
| SYYKDMLKAPSFERG | 101 | Q7Z388 | |
| AKYLDDRYEMEDGKV | 536 | O60503 | |
| IYDKAMKLEQEFGEY | 766 | Q92796 | |
| IKYYAKTGDTIEFMC | 536 | Q92496 | |
| RPVDMSKYLYADSSK | 346 | Q8NDI1 | |
| KRSLYVRAMFDYDKS | 536 | Q15700 | |
| GSIAYKEYEDMIATK | 436 | O60383 | |
| AVLTEAGDYTAKYMK | 346 | Q8IW92 | |
| AGDYTAKYMKLRDFF | 351 | Q8IW92 | |
| KTSLGMYSKEEEYVA | 1651 | Q9NYC9 | |
| TKVDEYGAKDYRLQM | 51 | P19447 | |
| AYNRGSRKKDDYMES | 561 | Q9NZU1 | |
| MESLKEDRTTLLYFY | 141 | Q14289 | |
| KGKYAYLLESTMNEY | 711 | P42261 | |
| AKYSDMSPVYRDKSG | 66 | Q5H9B9 | |
| RKVMDKYGEFYGRDR | 4651 | Q92736 | |
| YLDLKYSDMFKEINS | 641 | Q56UN5 | |
| LGETFIRYFVAMKKY | 476 | Q5TDP6 | |
| FTKYTEMDYARAGNK | 116 | Q9UKD2 | |
| DCRKMAKEYGDYFVV | 4316 | Q685J3 | |
| YSSAEYRLKEKFVMR | 481 | Q07890 | |
| YTRKAAALEAMKDYT | 431 | P31948 | |
| KARGMESKEDIPYYF | 456 | P09917 | |
| LGSYGKLKYYDTMTE | 361 | Q9UI40 | |
| KLKYYDTMTEEGRFR | 366 | Q9UI40 | |
| TTDYFLMEEKYFISK | 2056 | Q9P212 | |
| MDKALKEVFDYSYRD | 1 | Q9H3E2 | |
| KSYVEMLEFYGDRDG | 241 | Q15573 | |
| AEVTKKFYSMGCYEI | 186 | P35914 | |
| LEYTDSSYEEKKYTM | 21 | Q03013 | |
| KKYTMGDAPDYDRSQ | 31 | Q03013 | |
| LEYTDSSYEEKKYTM | 21 | P09488 | |
| KKYTMGDAPDYDRSQ | 31 | P09488 | |
| FAVKLAKYYRRMDSE | 811 | O43490 | |
| YRMKKKDEGSYSLEE | 276 | P18827 | |
| GKLLYLEDFFVMSDY | 86 | P21673 | |
| KRYEDEGIGSSYMFR | 1871 | Q9UPS6 | |
| AEDYAKERYGISSMI | 21 | P14868 | |
| YMEDKKDFTYDQVAF | 391 | P14410 | |
| FAEEERSKYDYLMIL | 296 | Q5VWP2 | |
| ASSLEEVKKEYASMY | 121 | Q7Z7C7 | |
| NARMDVTDKYKYPEG | 431 | Q08188 | |
| EYLMDRLEKESYFES | 246 | P55201 | |
| KRIYKTVADSDESYM | 101 | Q9HAW4 | |
| NYRIMSYFKEAELKD | 391 | P30291 | |
| TKDDKGYFRRLKYLM | 206 | P0CJ78 | |
| SYYDRTMQKPDKVED | 1116 | A4D1E1 | |
| KYYADGEDAYAMKRD | 136 | Q9BSU3 | |
| RKSEIEYYAMLAKTG | 56 | P62888 | |
| KYYNDYGDIIKETMS | 891 | Q8N3U4 | |
| QADKERDSMKVLYYV | 301 | Q71H61 | |
| DCVERKGKYMYFTVV | 241 | Q8WV24 | |
| KKRYENTDSDMGGYE | 246 | C9JQI7 | |
| TEQFYFTKMKEYLEG | 446 | O75044 | |
| YYEDLVEKSMGKYNL | 541 | Q6ZT07 | |
| SKKAREEMYEKYVAS | 351 | Q8WXW3 | |
| YELKDESLKDFNMYF | 821 | Q8IWV7 | |
| EAKSYRDALYKFMVD | 241 | P78562 | |
| RKLDVYFEYEEKIMS | 416 | Q8WVM8 | |
| YFEYEEKIMSKTTLD | 421 | Q8WVM8 | |
| MKALLRTKYGYFSES | 216 | O75830 | |
| KDFTGTSDPYVKMYL | 261 | Q6XYQ8 | |
| EEAAGTRMYEYKKIA | 166 | O95347 | |
| EGYVLFYRKSSEEAM | 676 | Q9Y2K6 | |
| GFRSYVDMYLKDKLD | 266 | P11388 | |
| KYAKFFEDYGLFMRE | 436 | Q12931 | |
| EGSDKKMEAEASYYL | 266 | Q8NA56 | |
| RAESIYEEMKQKYGT | 206 | Q9Y2L5 | |
| DLGDKYNSMEDAKVY | 101 | Q8NBS9 | |
| FSYLMTKYKLAVEFG | 256 | Q9NYW2 | |
| FREMGDYLKAKYDQA | 201 | Q9H1J5 | |
| LFEKYVFIGLYEKME | 166 | O15050 | |
| LNTGESFVMYYKSKE | 831 | Q9H9Y6 | |
| FEKTRYEMYVSILKE | 976 | Q9NYI0 | |
| MKKRYYDEVEAEGYV | 751 | P51784 | |
| YRKEAYLEMEFKEAI | 711 | Q14966 | |
| SRADDKGVMDYYLKY | 341 | O95365 | |
| KYTETLESIEKYFMA | 206 | Q9UKW4 | |
| EIEYAMAYSKAAFER | 116 | Q969H8 | |
| SKTMYVDYKTEDGSA | 426 | P57103 | |
| YDGPSYSKFTETRKM | 131 | Q9ULJ8 | |
| MQSGKEYRKDYEESI | 5931 | P20929 |